Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BlueDot

BlueDot?uq=8lCq2teR
2013 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Seed LATEST DEAL TYPE
3 INVESTORS
Description

Developer of a global early warning system for infectious diseases. The company's healthcare technologies integrate expertise in clinical medicine, public health, and software development, enabling governments, businesses, healthcare workers, and individuals to gain tailored insights to help them get ahead of infectious disease risks from seasonal influenza to outbreaks like Zika or Ebola.

Formerly Known As
BioDiaspora
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 209 Victoria Street
  • Toronto, Ontario
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BlueDot’s full profile, request a free trial.

BlueDot Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 02-Dec-2014 00000 Completed Generating Revenue
2. Grant 00000 00000 Completed Startup
1. Seed Round $400K $400K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BlueDot Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizons Ventures Venture Capital Minority 000 0000 000000 0
MaRS Innovation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Ontario Centres of Excellence Government Minority 000 0000 000000 0

BlueDot Executive Team (7)

Name Title Board
Seat
Contact
Info
James Yoon Director, Design
Tom Wang Director, Development
Lindsay Bryson Director, Strategy and Operations
Kamran Khan Founder

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »